July 2022

New Supplement Legislation in the Works

A new dietary supplement bill has been introduced in the Senate. It would require manufacturers to provide more product and label data upfront, but some question whether it would actually improve quality and transparency in the industry. The FDA is also taking steps to increase NDI filings, claiming that many manufacturers are selling products without approved NDIs.

We’ll keep you posted as legislation and FDA enforcement policies continue to develop. Stay tuned.

The information in this brief report is intended for informational purposes only, and is meant to help users better understand health concerns. This information should not be interpreted as specific medical advice. Users should consult with a qualified healthcare provider for specific questions regarding therapies, diagnosis and/or health conditions, prior to making therapeutic decisions. Copyright © 2023 NatMed. Commercial distribution or reproduction prohibited. NatMed is the leading provider of high-quality, evidence-based, clinically-relevant information on natural medicine, dietary supplements, herbs, vitamins, minerals, functional foods, diets, complementary practices, CAM modalities, exercises and medical conditions. Monograph sections include interactions with herbs, drugs, foods and labs, contraindications, depletions, dosing, toxicology, adverse effects, pregnancy and lactation data, synonyms, safety and effectiveness.